 purpose of this stud yis to estimate the effectiveness of AR-623 inducing a complete remission in first relapse acute promyocytic leukemia (APL) patients who have not received oral all-trans-retinoic acid (ATRA) within one year. Myocardial infarction (MI) has emerged as a major
purpose of this stud yis to estimate the effectiveness of AR-623 induce a accomplished remission in first relapse acute promyocytic leukemia (APL) patients who have not received oral all - trans - retinoic acid (ATRA) within one class. Myocardial infarction (MI) has emerged as a major
 pugpose of this stud yis tu estimate the gfdectivxness or AR-623 indjcing a complete remission ii fiest rtjapse acute promyozytic leunemia (APO) pauients who have not receiyzd orzp aln-vrans-retinoic agid (ATRA) widhin one year. Kyuccrdial infarction (MI) has emerged as w major
purpose of this stud yis to estimate of inducing a remission in first patients have not received all-trans-retinoic acid (ATRA) one year. Myocardial infarction (MI) has as a major
 purpose of this stud yis to estImate the efFectiVenEss Of aR-623 inDuciNg a complete remISsioN in first relapse acute prOmyocYtIC leuKEmIa (APL) PatientS WhO HAve NoT rEceIvED oRal alL-trAns-retiNoic acid (ATrA) wItHin one year. MyOCaRdial infarCtiOn (MI) has emergEd aS a majoR
 purpose of this stud yisto estimat e the  ef fec ti vene ss o f AR-623 induc i ng a  complete remission in  firs tr elap s eacute  promyo c yt i c  le uk em ia(A P L)  pati ent s who h ave not re cei ve d oral all-t r an s-retinoic  ac id (ATRA) wi thi n oneye ar. Myoca rdi al in farcti o n (MI)  has emer ge d  as am ajor
 purpose_of this_stud yis to estimate_the effectiveness_of_AR-623 inducing_a_complete remission in_first relapse acute_promyocytic leukemia (APL) patients_who have not_received_oral all-trans-retinoic acid (ATRA) within one year. Myocardial infarction (MI) has emerged as a_major